Funding
← Back to your selection

Omega Funds

Activity from announced rounds

Activity in this selectionOct 16, 2026 · Jul 19, 2026
Rounds participated in
2
Confirmed lead rounds
1
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$208M
2 disclosed · full round size, not this investor’s share

By stage

Series B1
Series C+1

By primary sector

Biotech1
Healthtech1

By country

Spain1
Switzerland1

Rounds

2 in this selection
Anaconda Biomed

Anaconda Biomed develops funnel-shaped thrombectomy catheters that help neurointerventional physicians remove clots during treatment of large-vessel-occlusion stroke.

$56MSeries C
Lead
Vaderis Therapeutics

Develops an oral AKT inhibitor for hereditary hemorrhagic telangiectasia

$152MSeries B
Role not disclosed